Abeona Therapeutics director buys 15,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Abeona Therapeutics Inc. (ABEO) director Faith L. Charles purchased 15,000 shares of common stock on November 13, 2026, at $2.2899 per share. The purchase brought reported direct holdings to 191,407 shares. No Rule 10b5-1 plan is reported for the purchase.
Insider Trade Summary
Net Buyer: 15,000 shares
Net Buy
1 txn
Insider
Charles Faith L.
Role
Director
Bought
15,000 shs ($34K)
Increase in Position
8.5%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 15,000 | $2.2899 | $34K |
Holdings After Transaction:
Common Stock — 191,407 shares (Direct)
Holdings Before and After:
Common Stock, 176,407 to 191,407 shares (Direct)
Key Figures
Shares purchased: 15,000 shares
Purchase price per share: $2.2899
Direct holdings after transaction: 191,407 shares
3 metrics
Shares purchased
15,000 shares
November 13, 2026
Purchase price per share
$2.2899
November 13, 2026
Direct holdings after transaction
191,407 shares
After the November 13, 2026 purchase
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.